News

5-6 июля 2021 года в научной столице России – Санкт-Петербурге пройдет II конференция GLP-PLANET , в рамках которой международные эксперты, представители регулятора, ведущие специалисты испытательных центров и фармацевтических компаний обсудят важнейшие вопросы, возникающие при проведении доклинических исследований:

• Эволюция требований к качеству доклинических исследований.
• Доклинические исследования: о чем не принято писать в научном отчете?
• Благополучие лабораторных животных.
• Разнообразие тест-систем и трансляционность полученных данных в клиническую практику.
• Аналитические лаборатории в доклинических и клинических исследованиях
• GLP-инжиниринг.
• Профессиональная подготовка специалистов в области доклинических исследований.

On the 30th of September in the framework of the round table “Interdisciplinary approach to the development of innovation and export capacity of the EAEU pharmaceutical industry” a discussion about GLP took place. All over the world GLP system is the basis of quality of laboratory studies. The level of implementation of this system in developed countries correlates with the export and innovation potential of the pharmaceutical industry. Drug manufacturers, laboratories (testing and bioanalytical), experts and regulators spoke about the stage of implementation and harmonization of the domestic GLP system and the prospects for its development in the EAEU. The full test is available in Russian.

October 1-3, 2020  hosted a regular Rus-LASA conference dedicated to application issues discussion of modern technologies of scientific research, education, regulatory and ethical issues in this area. Read more on the website Rus-LASA.

             

The innovative sphere, the main part of science and research works, nowadays is the fundamental factor of qualitative economic growth. At the same time, this sphere requires huge financial and material costs, as well as very high qualification of workers.

In the article “The cost of research work on pre-clinical studies”, published on the website of GMP news, Doctor of Medical Sciences, Professor Valery Makarov, General Director of St. Petersburg Institute of Pharmacy talked about the structure of preclinical study expenses and how the cost of preclinical studies is formed.

Рress release is available only in Russian https://gmpnews.ru/2020/07/pochemu-v-rossii-ne-rabotaet-sistema-pravil-nadlezhashhej-laboratornoj-praktiki/

Рress release is available only in Russian https://gmpnews.ru/2020/07/farmrynok-zhdet-edinogo-regulyatora-v-oblasti-glp-inspekcij/

Expert opinion https://gmpnews.ru/nash-otvet-covid-19/  [Only in Russian].

Details in the article https://gmpnews.ru/2020/04/chto-meshaet-vnedreniyu-glp-v-rossii/ [full text is available in Russian]